59.40
5.86%
3.29
Exact Sciences Corp Azioni (EXAS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
1.45%
637.52
|
646.88 | 628.34 | 622.09 | 602.45 |
Cost Of Revenue |
1.03%
170.10
|
171.87 | 168.53 | 156.99 | 156.87 |
Gross Profit |
1.60%
467.42
|
475.02 | 459.81 | 465.10 | 445.58 |
Operating Expenses
|
5.76%
574.12
|
542.86 | 452.96 | 542.03 | 522.67 |
Benefits Costs and Expenses |
6.98%
745.95
|
697.26 | 627.29 | 702.01 | 674.94 |
Costs And Expenses |
3.16%
743.95
|
721.13 | 693.52 | 699.02 | 679.54 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
57.27%
-106.69
|
-67.84 | 6.849 | -76.93 | -77.09 |
Net Interest Income/Expense |
-7.943
|
- | -7.871 | -7.818 | 4.107 |
Nonoperating Income/Loss |
109.91%
-1.73
|
17.46 | -5.806 | -2.99 | 4.597 |
Income/Loss From Continuing Operations Before Tax |
115.23%
-108.42
|
-50.38 | 1.043 | -79.92 | -72.49 |
Income Tax Expense/Benefit, Deferred |
1.797
|
- | -0.951 | -0.589 | 1.261 |
Income Tax Expense/Benefit |
396.07%
1.806
|
-0.61 | 0.249 | 1.107 | 1.657 |
Income/Loss From Continuing Operations After Tax |
121.49%
-110.23
|
-49.77 | 0.794 | -81.03 | -74.15 |
Net Income/Loss
|
121.49%
-110.23
|
-49.77 | 0.794 | -81.03 | -74.15 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
55,665%
182.35
|
0.327 | 180.65 | 180.20 | 178.57 |
Basic Earnings Per Share |
122.22%
-0.60
|
-0.27 | - | -0.45 | -0.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):